Ibrutinib, a Bruton's tyrosine kinase inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil activation test reactivity

伊布替尼是一种布鲁顿酪氨酸激酶抑制剂，用于治疗淋巴增生性疾病，它能消除吸入性过敏原皮肤试验和嗜碱性粒细胞活化试验的反应性。